Quantification of Residual Cancer Burden and Outcome
8
Genomic Predictor for Response and Survival
9
Protocol 2014 - 0812: Assessment of the Tumor Response to Neoadjuvant Chemotherapy in Women with Invasive Breast Cancer using Tc99m sestamibi Molecular Breast Imaging: A Prospective Study
10
Tc 99m Sestamibi
11
Preliminary Results
12
Cytoreduction with Laparoscopic Assessment
13
MOON SHOTS PROGRAM
Description:
Explore a Yale Radiology & Biomedical Imaging Grand Rounds lecture on cancer imaging opportunities related to MD Anderson's Cancer Moonshot initiative. Delve into CT texture analysis, quantification methods for residual cancer burden, genomic predictors for treatment response, and innovative imaging techniques like molecular breast imaging using Tc-99m sestamibi. Gain insights on the Moon Shots Program and its impact on immunotherapy platforms. Learn about cutting-edge approaches in diagnostic radiology for cancer assessment and treatment monitoring from Dr. Wei Yang, Professor and Chair of Diagnostic Radiology at The University of Texas MD Anderson Cancer Center.
Imaging Opportunities Around Cancer Moonshot Platforms at MD Anderson Cancer Center